Daxor Retained Earnings (Accumulated Deficit) 2010-2011 | DXR

Daxor retained earnings (accumulated deficit) from 2010 to 2011. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Daxor Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2011 $25
2010 $33
2009 $32
Daxor Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2011-12-31 $25
2011-09-30 $27
2011-06-30 $31
2011-03-31 $32
2010-12-31 $33
2010-09-30 $33
2010-06-30 $32
2010-03-31 $32
2009-12-31 $32
2009-09-30 $38
2009-06-30 $36
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.379B 12.93
Quest Diagnostics (DGX) United States $17.308B 17.75
DaVita (DVA) United States $13.689B 16.84
Encompass Health (EHC) United States $9.303B 22.88
Chemed (CHE) United States $8.694B 26.73
Elanco Animal Health (ELAN) United States $7.242B 16.28
Option Care Health (OPCH) United States $5.321B 26.14
RadNet (RDNT) United States $4.963B 117.74
Amedisys (AMED) United States $3.181B 22.75
Astrana Health (ASTH) United States $2.805B 39.69
LifeStance Health (LFST) United States $2.579B 0.00
Addus HomeCare (ADUS) United States $2.399B 29.12
U.S Physical Therapy (USPH) United States $1.274B 34.50
Pennant (PNTG) United States $1.057B 50.71
Aveanna Healthcare Holdings (AVAH) United States $1.022B 0.00
Atai Life Sciences (ATAI) Germany $0.208B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.006B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00